Samrat Pharmachem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 23 shareholders own 63.05% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14%	Lalit Mehta	431,498	₹195.4m	0%	no data
12.4%	Rajesh Mehta	383,542	₹173.7m	0%	no data
5.67%	Premal Mehta	175,281	₹79.4m	0%	no data
4.5%	Kaushal Mehta	139,065	₹63.0m	0%	no data
3.86%	Jaya Mehta	119,300	₹54.0m	0%	no data
3.27%	S. Sangeetha	101,000	₹45.7m	0%	no data
3.24%	Lloyds Securities Overseas Ltd	100,000	₹45.3m	0%	no data
2.66%	Rupal Mehta	82,182	₹37.2m	0%	no data
2.15%	Falguni Mehta	66,400	₹30.1m	0%	no data
2.11%	Golechha Global Finance Limited, Asset Management Arm	65,240	₹29.5m	0%	no data
1.71%	Megh Mehta	52,882	₹23.9m	13.4%	no data
1.64%	Kalpana Mehta	50,600	₹22.9m	0%	no data
1.53%	Alert Consultants & Credit Private Limited, Asset Management Arm	47,169	₹21.4m	0%	no data
1.31%	Anshul Specialty Molecules Private Limited	40,444	₹18.3m	0%	no data
1.13%	Sharad Shah	35,000	₹15.8m	0%	no data
0.42%	Rajasthan Global Securities Limited, Asset Management Arm	13,087	₹5.9m	0%	0.04%
0.4%	Divyanshu Kantol	12,500	₹5.7m	0%	no data
0.38%	Maitri Mehta	11,744	₹5.3m	42.5%	no data
0.36%	Ponguleti Reddy	10,971	₹5.0m	0%	no data
0.32%	Rajendra Sanghavi	10,000	₹4.5m	0%	no data
0.0065%	Samir Kothary	200	₹90.5k	0%	no data
0.00081%	Mahendra Pipalia	25	₹11.3k	0%	no data
0.00081%	Renu Dharod	25	₹11.3k	0%	no data